• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Acadia Healthcare Company Inc.

    2/9/24 8:35:54 AM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email
    SC 13G 1 filing.txt SCHEDULE 13G Amendment No.0 ACADIA HEALTHCARE CO INC COMMON STOCK Cusip #00404A109 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00404A109 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 5,010,061 Item 6: 0 Item 7: 5,013,644 Item 8: 0 Item 9: 5,013,644 Item 11: 5.436% Item 12: HC Cusip #00404A109 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 5,013,644 Item 8: 0 Item 9: 5,013,644 Item 11: 5.436% Item 12: IN Item 1(a). Name of Issuer: ACADIA HEALTHCARE CO INC Item 1(b). Address of Issuer's Principal Executive Offices: 6100 TOWER CIRCLE, SUITE 1000 FRANKLIN, TN 37067 US Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 00404A109 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 5,013,644 (b) Percent of Class: 5.436% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 5,013,644 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of ACADIA HEALTHCARE CO INC. No one other person's interest in the COMMON STOCK of ACADIA HEALTHCARE CO INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Diversifying Solutions LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC IA Strategic Advisers LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of ACADIA HEALTHCARE CO INC at December 29, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $ACHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    4/25/2024$70.00Sell → Hold
    Deutsche Bank
    3/6/2024$100.00Overweight
    Barclays
    4/21/2023$83.00Neutral
    Cantor Fitzgerald
    4/20/2023$75.00 → $63.00Hold → Sell
    Deutsche Bank
    More analyst ratings

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Acadia Healthcare Reports First Quarter 2025 Results

      Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

      5/12/25 4:07:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare to Participate in BofA Securities Health Care Conference

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference, May 13-15, 2025, in Las Vegas, Nevada. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 1:20 p.m. Central Time / 11:20 a.m. Pacific Time on Wednesday, May 14th, 2025. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading provider of behavi

      5/8/25 11:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

      Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri

      4/16/25 8:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/14/24 1:28:32 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/12/24 9:50:14 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/8/24 10:52:39 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $ACHC
    SEC Filings

    See more

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ACHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Acadia Healthcare downgraded by Barclays with a new price target

      Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously

      2/28/25 7:39:54 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00

      1/7/25 7:39:01 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Acadia Healthcare from Hold to Buy and set a new price target of $75.00 from $45.00 previously

      12/12/24 8:38:21 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      5/12/25 4:38:36 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Acadia Healthcare Company Inc.

      10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      5/12/25 4:30:31 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Acadia Healthcare Company Inc.

      DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      4/10/25 5:03:34 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Chief Executive Officer Hunter Christopher H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 0.71% to 263,994 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/13/25 5:01:03 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Chief Financial Officer Dixon Heather Brianne was granted 43,823 shares, increasing direct ownership by 56% to 122,499 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 6:02:50 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • EVP, GC and Secretary Farley Brian was granted 38,606 shares, increasing direct ownership by 112% to 73,022 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 5:57:46 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R

      4/11/24 2:16:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i

      4/4/24 9:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital

      Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For

      2/20/24 1:00:00 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Financials

    Live finance-specific insights

    See more
    • Acadia Healthcare Reports First Quarter 2025 Results

      Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

      5/12/25 4:07:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

      Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri

      4/16/25 8:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Reports Fourth Quarter 2024 Results

      Company Provides Full Year and First Quarter 2025 Guidance, Announces $300 Million Share Repurchase Authorization Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjusted income attributab

      2/27/25 4:05:00 PM ET
      $ACHC
      Medical Specialities
      Health Care